​

DaVita (DVA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

DVA Stock Forecast

DaVita (DVA) stock forecast, based on 21 Wall Street analysts, predicts a 12-month average price target of $184.00, with a high of $184.00 and a low of $184.00. This represents a 31.40% increase from the last price of $140.03.

$100 $117 $134 $151 $168 $185 High: $184 Avg: $184 Low: $184 Last Closed Price: $140.03

DVA Stock Rating

DaVita stock's rating consensus is Hold, based on 21 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (38.10%), 13 Hold (61.90%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 21 0 13 8 Strong Sell Sell Hold Buy Strong Buy

DVA Price Target Upside V Benchmarks

TypeNameUpside
StockDaVita31.40%
SectorHealthcare Stocks 35.94%
IndustryMedical Care Facilities Stocks24.63%

Price Target Trends

1M3M12M
# Anlaysts-13
Avg Price Target-$184.00$159.67
Last Closing Price$140.03$140.03$140.03
Upside/Downside-31.40%14.03%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25-18-110
Mar, 25-18-110
Feb, 25-17-19
Jan, 25-17-210
Dec, 24117-211
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 21, 2025Lisa Bedell CliveBernstein$184.00$142.4029.21%31.40%
Aug 07, 2024Kevin FischbeckBank of America Securities$145.00$133.538.59%3.55%
May 06, 2024Andrew MokBarclays$150.00$134.4511.57%7.12%
Oct 31, 2022Sarah JamesBarclays$81.00$70.5414.83%-42.16%
Aug 19, 2022Andrew MokUBS$117.00$93.1025.67%-16.45%
Jun 28, 2022David MacDonaldTruist Financial$90.00$79.4413.29%-35.73%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 18, 2025Cowen & Co.HoldHoldhold
May 06, 2024BarclaysEqual-WeightEqual-Weighthold
Jan 05, 2023CFRAHoldupgrade
Aug 19, 2022UBSBuyupgrade
Jun 28, 2022BarclaysEqual-WeightEqual-Weighthold

Financial Forecast

EPS Forecast

$5 $8 $11 $14 $17 $20 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$6.54$9.30$8.26$7.62$11.02----
Avg Forecast$7.45$8.89$6.21$7.98$9.69$11.41$13.71$15.04$16.96
High Forecast$7.58$9.04$6.25$8.10$9.76$12.05$15.54$16.82$17.41
Low Forecast$7.35$8.76$6.15$7.77$9.64$10.75$11.99$13.26$16.81
Surprise %-12.21%4.61%33.01%-4.51%13.73%----

Revenue Forecast

$11B $12B $13B $14B $15B $16B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$11.55B$11.62B$11.61B$12.14B$12.82B----
Avg Forecast$11.57B$11.59B$11.62B$12.01B$12.78B$13.33B$13.79B$14.53B$15.02B
High Forecast$11.73B$11.74B$11.69B$12.04B$12.83B$13.37B$13.81B$14.61B$15.33B
Low Forecast$11.44B$11.46B$11.55B$11.98B$12.74B$13.29B$13.78B$14.44B$14.92B
Surprise %-0.19%0.28%-0.12%1.11%0.25%----

Net Income Forecast

$0 $400M $800M $1B $2B $2B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$773.64M$978.45M$768.19M$691.53M$936.34M----
Avg Forecast$603.16M$838.97M$839.66M$691.53M$903.84M$1.06B$1.28B$1.40B$1.58B
High Forecast$723.79M$1.01B$1.01B$829.84M$909.42M$1.12B$1.45B$1.57B$1.62B
Low Forecast$482.53M$671.18M$671.73M$553.23M$898.26M$1.00B$1.12B$1.24B$1.57B
Surprise %28.26%16.63%-8.51%-3.60%----

DVA Forecast FAQ

Is DaVita stock a buy?

DaVita stock has a consensus rating of Hold, based on 21 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 13 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that DaVita is a neutral investment for most analysts.

What is DaVita's price target?

DaVita's price target, set by 21 Wall Street analysts, averages $184 over the next 12 months. The price target range spans from $184 at the low end to $184 at the high end, suggesting a potential 31.40% change from the previous closing price of $140.03.

How does DaVita stock forecast compare to its benchmarks?

DaVita's stock forecast shows a 31.40% upside, underperforming the average forecast for the healthcare stocks sector (35.94%) and outperforming the medical care facilities stocks industry (24.63%).

What is the breakdown of analyst ratings for DaVita over the past three months?

  • April 2025: 0% Strong Buy, 10.00% Buy, 80.00% Hold, 0% Sell, 10.00% Strong Sell.
  • March 2025: 0% Strong Buy, 10.00% Buy, 80.00% Hold, 0% Sell, 10.00% Strong Sell.
  • February 2025: 0% Strong Buy, 11.11% Buy, 77.78% Hold, 0% Sell, 11.11% Strong Sell.

What is DaVita’s EPS forecast?

DaVita's average annual EPS forecast for its fiscal year ending in December 2025 is $11.41, marking a 3.54% increase from the reported $11.02 in 2024. Estimates for the following years are $13.71 in 2026, $15.04 in 2027, and $16.96 in 2028.

What is DaVita’s revenue forecast?

DaVita's average annual revenue forecast for its fiscal year ending in December 2025 is $13.33B, reflecting a 3.98% increase from the reported $12.82B in 2024. The forecast for 2026 is $13.79B, followed by $14.52B for 2027, and $15.02B for 2028.

What is DaVita’s net income forecast?

DaVita's net income forecast for the fiscal year ending in December 2025 stands at $1.06B, representing an 13.46% increase from the reported $936.34M in 2024. Projections indicate $1.28B in 2026, $1.4B in 2027, and $1.58B in 2028.